Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Mol. Biosci., 09 December 2025

Sec. Molecular Diagnostics and Therapeutics

Volume 12 - 2025 | https://doi.org/10.3389/fmolb.2025.1658908

Correction: Development of a prognostic model for early-stage gastric cancer-related DNA methylation-driven genes and analysis of immune landscape

Chen Su,,&#x;Chen Su1,2,3Zeyang Lin&#x;Zeyang Lin4Zhijian Ye,&#x;Zhijian Ye2,3Jing LiangJing Liang5Rong Yu,
Rong Yu2,3*Zheng Wan
Zheng Wan6*Jingjing Hou,,
Jingjing Hou1,2,3*
  • 1The School of Clinical Medical, Fujian Medical University, Fuzhou, Fujian, China
  • 2Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
  • 3Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, China
  • 4Department of Pathology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China
  • 5Department of Pathology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
  • 6Department of Minimally Invasive and Interventional Therapy for Cancer, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen, China

A Corrigendum on
Development of a prognostic model for early-stage gastric cancer-related DNA methylation-driven genes and analysis of immune landscape

by Su C, Lin Z, Ye Z, Liang J, Yu R, Wan Z and Hou J (2024). Front. Mol. Biosci. 11:1455890. doi: 10.3389/fmolb.2024.1455890

In the Funding statement, the name of one of the funders was incorrectly provided as Foundation of Xiamen Municipal Bureau of Science and Technology. The correct funder is Natural Science Foundation of Xiamen, China.

An incorrect number was provided for the Natural Science Foundation of Fujian Province. The correct number is No. 2023J011600.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: gastric cancer, FAAH, C1orf35, DNA methylation-driven gene, prognosis

Citation: Su C, Lin Z, Ye Z, Liang J, Yu R, Wan Z and Hou J (2025) Correction: Development of a prognostic model for early-stage gastric cancer-related DNA methylation-driven genes and analysis of immune landscape. Front. Mol. Biosci. 12:1658908. doi: 10.3389/fmolb.2025.1658908

Received: 03 July 2025; Accepted: 19 August 2025;
Published: 09 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Su, Lin, Ye, Liang, Yu, Wan and Hou. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Rong Yu, eXJvbmcwNTAyQDE2My5jb20=; Zheng Wan, d2FuemhlbmcwNjI2QHhtdS5lZHUuY24=; Jingjing Hou, ampob3VAeG11LmVkdS5jbg==

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.